Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10 mio shares traded without any price movement

Could be.... but they are showing them as long term investrments right now and we've borrowed 3.5 Mm against them already...which is in the $7MM+ cash on hand we had at the Q....cash per share and assets per share are much different numbers..

From last Q numbers

Balance Sheet
Total Cash (mrq): 7.66M
Total Cash Per Share (mrq): 0.019
Total Debt (mrq):

3.29M

Even if we get the remaining balance of the ARS that leaves us about another $7MM after our repayment of the loan against them...subtract out our operating exp. of about 2.3MM and with only one license last quarter we may only see a few 100K from that after the split (remember we're paying TPL another 500K at least for their "special services with PDS)...then our cash per share won't come near 5 cents.

Even if we got all of our ARS back, paid off the loan, deducted our avg. expense from last Q, and added in another 300k from PDS we would still only make about 3 cents per share..with all of that happening in our favor.

7.66 (last Q) + 7.50 (net from ARS cash out)+300k (from PDS)....minus 2.3MM exp. and we get a total cash of about 13MM or 3 cents a share...with over 400k shares out there and growing ...we will need $20MM +++ to get that 5 cent a share balance





Share
New Message
Please login to post a reply